CELCUITY
Celcuity is a clinical-stage biotechnology company translating discoveries of new cancer sub-types into pioneering companion diagnostics and expanded therapeutic options for cancer patients. Celcuity's 3rd generation diagnostic platform, CELsignia, analyzes living tumor cells to untangle the complexity of the cellular activity driving a patient's cancer. This allows Celcuity to discover new cancer sub-types molecular diagnostics cannot detect. Celcuity is driven to improve outcomes for patients and to transform how pharmaceutical companies define the patient populations for their targeted therapies.
CELCUITY
Industry:
Biotechnology Health Care Health Diagnostics Therapeutics
Founded:
2012-01-01
Address:
Hamel, Minnesota, United States
Country:
United States
Website Url:
http://www.celcuity.com
Total Employee:
11+
Status:
Active
Contact:
763-473-0341
Total Funding:
143.67 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Similar Organizations
Akebia Therapeutics
Akebia Therapeutics develops treatments for ischemia and vascular diseases.
Cellics Therapeutics
Cellics is committed to saving lives and improving patients’ health using innovative biomimetic nanomedicines.
Pliant Therapeutics
Pliant Therapeutics focuses on discovering, developing, and commercializing breakthrough treatments for fibrotic diseases.
Scout Bio
Scout Bi is a biotechnology company that provides veterinary, animal health, and gene therapy.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
New Enterprise Associates
New Enterprise Associates investment in Post-IPO Equity - Celcuity
Venrock Healthcare Capital Partners
Venrock Healthcare Capital Partners investment in Post-IPO Equity - Celcuity
RA Capital Management
RA Capital Management investment in Post-IPO Equity - Celcuity
Commodore Capital
Commodore Capital investment in Post-IPO Equity - Celcuity
Soleus Capital
Soleus Capital investment in Post-IPO Equity - Celcuity
Brian Sullivan
Brian Sullivan investment in Post-IPO Equity - Celcuity
Brightstone Venture Capital
Brightstone Venture Capital investment in Series A - Celcuity
Official Site Inspections
http://www.celcuity.com Semrush global rank: 3.33 M Semrush visits lastest month: 4.81 K
- Host name: 164.77.69.34.bc.googleusercontent.com
- IP address: 34.69.77.164
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Celcuity"
Our Team - Celcuity
Before joining Celcuity, Fred was VP of Clinical Operations at CytomX Therapeutics where he oversaw the execution of their oncology programs, including a Phase 2 program in breast …See details»
Celcuity - Crunchbase Company Profile & Funding
Celcuity is a biotechnology company translating discoveries of new cancer sub-types into expanded therapeutic options for cancer patients.See details»
Celcuity Inc. (CELC) Company Profile & Facts - Yahoo Finance
See the company profile for Celcuity Inc. (CELC) including business summary, industry/sector information, number of employees, business summary, corporate governance, key executives …See details»
Celcuity – Investor Relations
4 days ago Celcuity is a clinical-stage biotechnology company pursuing development of targeted therapies for treatment of multiple solid tumor indications. The company’s lead therapeutic …See details»
Careers - Celcuity
Careers at Celcuity Celcuity is a clinical-stage biotechnology company pursuing development of targeted therapies for oncology. Our lead product candidate, gedatolisib, is a potential first-in …See details»
Our Pipeline - Celcuity
Pursuing first-in-class targeted therapies The PI3K/mTOR pathway has been implicated in breast, prostate, endometrial, ovarian and hematological cancers, among others. We are currently developing our lead drug candidate, …See details»
Board of Directors - Celcuity
Dave has served as a member of Celcuity’s board of directors since February 2014. Dave has more than 30 years of experience in the fields of corporate finance and venture capital, working primarily with growth-oriented technology …See details»
Celcuity Company Profile - Office Locations, Competitors ... - Craft
Oct 29, 2024 Celcuity has 4 employees at their 1 location. See insights on Celcuity including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
Celcuity: Revenue, Worth, Valuation & Competitors 2025
Celcuity is a biotech company developing state-of-the-art cell-based assays using their proprietary functional cellular analysis platform. They directly assess the functionality of the disease …See details»
Celcuity Inc. - AnnualReports.com
Celcuity is a clinical stage biotechnology company translating discoveries of new cancer sub-types into pioneering companion diagnostics and expanded therapeutic options for cancer patients. Celcuity's 3rd generation diagnostic …See details»
Press Releases – Celcuity – Investor Relations
PRIVACY POLICY ACCESSIBILITY STATEMENT Follow us on Celcuity Headquarters 16305 – 36th Avenue North Suite 100 Minneapolis, MN 55446See details»
Celcuity - LinkedIn
Celcuity | 4,156 followers on LinkedIn. Celcuity is a clinical-stage, publicly traded biotechnology company seeking to extend the lives of cancer patients through the development of targeted …See details»
Our Team – Celcuity – Investor Relations
Before joining Celcuity, Pratima was the Senior Medical Director at Atara Biotherapeutics. She led the medical affairs activities to develop a leading allogeneic T-cell therapy in the US and …See details»
Celcuity Inc - Company Profile and News - Bloomberg Markets
3 days ago Company profile page for Celcuity Inc including stock price, company news, executives, board members, and contact informationSee details»
CELCUITY INC. COMPENSATION COMMITTEE CHARTER I.
The Board of Directors (“Board”) of Celcuity Inc., a Delaware corporation (“Company”), has adopted this charter to govern the operation of the Compensation Committee (“Committee”).See details»
Celcuity: What’s Happening With CELC Stock? - Forbes
3 days ago Celcuity stock (NASDAQ: CELC), a clinical-stage biotechnology company, experienced an extraordinary 3x surge in a single trading session, with shares rocketing from …See details»
Analyst Coverage – Celcuity – Investor Relations
© Celcuity Inc. 16305 36 th Avenue North Minneapolis, MN 55446See details»
Celcuity - Work in biotech
Celcuity is seeking to extend the lives of cancer patients by translating discoveries of new cancer subtypes into expanded therapeutic options. Targeted therapies only work if they inhibit the …See details»
Celcuity - Contacts, Employees, Board Members, Advisors & Alumni
Celcuity is a biotechnology company translating discoveries of new cancer sub-types into expanded therapeutic options for cancer patients.See details»
Celcuity's breast cancer combo hits goals, teeing up FDA filing
4 days ago A phase 3 trial of Celcuity’s breast cancer combination has hit its primary endpoints, blasting past the biotech’s bar for success to tee up a filing for FDA approval in the fourth …See details»